Active	Status	Sponsor type	Region	Phase	Filter
6 Active 1 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fraser, Asad
RA-BRANCH, NCT04086745: A Study of Baricitinib in Participants With Rheumatoid Arthritis	Recruiting	4	1300	US	Baricitinib, LY3009104, TNF Inhibitor, Etanercept, Adalimumab	Eli Lilly and Company, Incyte Corporation	Rheumatoid Arthritis	12/24	02/26
NCT06130540: Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR	Recruiting	1	60	Europe, US, RoW	Secukinumab, AIN457	Novartis Pharmaceuticals	Giant Cell Arteritis, Polymyalgia Rheumatica	05/25	07/25
Diri, Erdal
BE-EARLY, NCT06411249: A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)	Recruiting	4	350	Europe, Japan, US, RoW	Belimumab (GSK1550188), BEL (BENLYSTA)	GlaxoSmithKline	Systemic Lupus Erythematosus	04/27	05/29
RA-BRANCH, NCT04086745: A Study of Baricitinib in Participants With Rheumatoid Arthritis	Recruiting	4	1300	US	Baricitinib, LY3009104, TNF Inhibitor, Etanercept, Adalimumab	Eli Lilly and Company, Incyte Corporation	Rheumatoid Arthritis	12/24	02/26
NCT04314531: Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)	Active, not recruiting	3	292	Europe, Japan, US, RoW	TILD, matching placebo injections	Sun Pharmaceutical Industries Limited	Active Psoriatic Arthritis	09/24	12/24
NCT04314544: Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)	Recruiting	3	472	Europe, Canada, US, RoW	TILD, matching placebo injections	Sun Pharmaceutical Industries Limited	Active Psoriatic Arthritis	05/25	02/26